Navigation Links
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Date:4/9/2013

rom an academic idea to preclinical proof-of-concept and there's a reasonably high probability that the company's development programs will result in new therapeutics for patients with difficult-to-treat tumors," said Larry Lasky , Ph.D., partner at US Venture Partners and Cleave director.

Cleave's lead program is discovering small molecules that target p97, a central player in the ubiquitin proteasome and autophagy pathways that are intimately involved in controlling protein degradation. Targeting protein degradation has been validated by the commercial success of VELCADE® (bortezomib) and KYPROLIS® (carfilzomib) in multiple myeloma. P97 inhibition is a novel approach that has the potential to treat a wide range of cancers.

"Cleave Biosciences has made substantial progress in identifying and optimizing small molecules against a number of novel targets and is progressing its lead program toward the clinic," said Dr. Garland. "We are pleased to join Cleave's investor syndicate to help fuel the company's momentum."

Dr. Garland and his colleagues at NEA, one of the world's largest and most active venture capital firms, have a long track record of partnering with companies that have pioneered transformative innovations in healthcare. Prior to NEA, in addition to clinical practice at the University of California, San Francisco (UCSF), Dr. Garland was with McKinsey & Company's Pharmaceutical & Medical Products and Corporate

Finance & Strategy practices. Dr. Garland completed his Residency in Internal Medicine and Fellowship in Infectious Diseases at UCSF, and received his M.B.A. and M.P.H. from the University of California, Berkeley, his M.D. from Baylor College of Medicine and his B.S. in Electrical Engineering/Bioengineering from Rice University.

About Cleave Biosciences

Cleave Biosciences is discovering and developing novel small molecule therapies for difficult-to-treat cance
'/>"/>

SOURCE Cleave Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SAN DIEGO , Aug. 29, 2014 /PRNewswire/ ... an emerging biopharmaceutical company, announced today that Santosh ... will be leaving the Company, for personal reasons, ... the Chief Medical Officer of Aires Pharmaceuticals, which ... Vetticaden,s former responsibilities as the Company,s interim Chief ...
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the ... acquired Polaris Medical Imaging, a leader in sales, service ... strategic acquisition allows BC Technical to continue to expand ... within MR and CT modalities. "We ... said Mark Alvarez , president and CEO of ...
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4BC Technical Acquires Polaris Medical Imaging 2US CNS Disorders Drug Pipeline Insight 2014 2
... 2010 General-use X-ray security systems are one ... to widespread use to check people entering secured ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... the low risk to health associated with these ...
... N.Y., Nov. 4, 2010 At a special meeting today, ... approve the merger of West Acquisition Corp., an indirect wholly ... ), with and into Penwest and voted to approve the ... Penwest, West and Endo.   The merger became ...
Cached Medicine Technology:
(Date:8/31/2014)... August 31, 2014 The severity of ... provider specializing in menopause is expert in helping ... and relief from uncomfortable symptoms with the latest treatment ... therapies offer a variety of alternative treatments and products ... these treatment options may fall outside of what can ...
(Date:8/31/2014)... Sunday 31 August 2014: Drinking tea reduces non-cardiovascular ... people presented at ESC Congress today by Professor Nicolas ... have to choose between tea or coffee it,s probably ... components of our way of life. Their effects on ... with sometimes divergent results. We investigated the effects of ...
(Date:8/30/2014)... Spain Sunday 31 August 2014: Local anaesthetic is ... (TAVI) as general anaesthetic, according to results of the ... Dr Romain Chopard from France. , Dr Chopard said: ... treatment alternative for patients with severe symptomatic aortic stenosis ... conventional surgical aortic valve replacement. The number of TAVI ...
(Date:8/30/2014)... Orlando, Florida (PRWEB) August 31, 2014 ... gait walking and how a mobility device can help in ... now available for free download from the website that contains ... medical doctor for this site. , The articles deal with ... mobility device like a walking cane can help in making ...
(Date:8/30/2014)... In a world where a typical response ... Group, LLC launches a game app to teach another way. ... Ultimate Karma app is a colorful way to encourage moral ... the game pulls double-duty by teaching players new ways to ... to reward gamers for consistently taking the high road, the ...
Breaking Medicine News(10 mins):Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2
... , SATURDAY, June 20 (HealthDay News) -- Mowing the ... people forget that their lawn mower can cause serious ... States, about 200,000 people (including 16,000 children) are injured ... Product Safety Commission. Those injuries include severed fingers, toes ...
... 600 Kidney-Friendly Recipes to Meet Kidney Care Needs for Dads ... Inc. (NYSE: DVA ), a leading provider of ... (CKD), offers fathers and their families the opportunity to enjoy ... 600 kidney-friendly recipes available on DaVita.com . ...
... U.S. Senator Amy Klobuchar to visit Healthy Athletes Village and ... Today is the last day to catch Summer Games action ... Klobuchar will visit Healthy Athletes Village today from 9:30-10 a.m. ... from 10-10:30 a.m. at Bierman Field. , , Healthy ...
... imaging equipment is in use in outpatient settings does ... Payment Advisory Commission (MedPAC) recommend Medicare utilize to calculate ... the Radiology Business Management Association (RBMA), a national association ... data, which consist of 261 imaging machines in 46 ...
... , SEATTLE, June 19 /PRNewswire-FirstCall/ -- ... CTIC) today announced the final results of its separate concurrent ... the "Exchange Offers") for any and all of the approximately ... convertible notes (the "Notes"). The Exchange Offers expired at ...
... As President Obama prepares to sign a bill giving ... tobacco industry, a new study from Harvard School of ... continually changed the ingredients and the design of their ... acceptable product variance guidelines. The result, say the researchers, ...
Cached Medicine News:Health News:Don't Get Lazy About Lawn-Mower Safety 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 3Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 2Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 2Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 4Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 2Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 3Health News:Study finds that tobacco companies changed design of cigarettes without alerting smokers 2
... in the field of point of diagnostics pathology, ... a back-up instrument in routine pathology laboratories. With ... for the cover, the CM1100 can be transported ... transformer, it can be run on a car ...
... The OTF5000 represents the new ... the long-established and reliable OTF/AS cryostat, ... blade systems in the ever-reliable and ... of options plus money-saving package deals ...
... The HM 560 Cryo-Star - ... have been incorporated which offer the ... electronic, optionally motorized cryostat with retraction ... for independent specimen and knife cooling. ...
... new tissue infiltration instrument, which combines well-proven ... The robust caroussel design is proven and ... instrument includes either 10 reagent and 2 ... paraffin containers. Up to 10 different programs ...
Medicine Products: